BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Relief Therapeutics

Relief Therapeutics logo


Relief Therapeutics is a publicly-traded drug development company focusing primarily on the clinical development of peptides and proteins of natural or engineered origin. They produce and commercialize atexakin alfa, for the treatment of neuropathies. The company currently focuses on diabetic complications and respiratory diseases.

Relief Therapeutics was founded in 2013 and is headquartered in Switzerland.

Get access to BPT Crunch to view additional information about this company